News Biogen drug shows potential in Alzheimer's Phase 1b trial shows aducanumab clears brain plaques.
News Shire launches potential blockbuster dry eye drug in US Xiidra could be ophthalmology blockbuster.
News Amgen's Prolia succeeds in glucocorticoid-induced osteoporos... Possible new use for well-established drug.
Views & Analysis Trends in clinical research in China A large patient pool plus growing market opportunities are making China increasingly attractive for clinical trials.
Views & Analysis Promise for combination approach to cancer As immuno-oncology increasingly involves more than one agent for best efficacy, market positioning must take a pan-tumour approach.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
